BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9645922)

  • 1. TNF, apoptosis and autoimmunity: a common thread?
    Beutler B; Bazzoni F
    Blood Cells Mol Dis; 1998 Jun; 24(2):216-30. PubMed ID: 9645922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways.
    Mountz JD; Zhou T; Su X; Cheng J; Pierson M; Bluethmann H; Edwards CK
    Behring Inst Mitt; 1996 Oct; (97):200-19. PubMed ID: 8950477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils.
    Cassatella MA
    J Leukoc Biol; 2006 Jun; 79(6):1140-9. PubMed ID: 16574768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha.
    Herr I; Posovszky C; Di Marzio LD; Cifone MG; Boehler T; Debatin KM
    Oncogene; 2000 Aug; 19(37):4255-62. PubMed ID: 10980599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Messengers of cell death: apoptotic signaling in health and disease.
    Rossi D; Gaidano G
    Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.
    Grell M; Zimmermann G; Gottfried E; Chen CM; Grünwald U; Huang DC; Wu Lee YH; Dürkop H; Engelmann H; Scheurich P; Wajant H; Strasser A
    EMBO J; 1999 Jun; 18(11):3034-43. PubMed ID: 10357816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic signaling cascades.
    Ashe PC; Berry MD
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):199-214. PubMed ID: 12657360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.
    Gong B; Almasan A
    Cancer Res; 2000 Oct; 60(20):5754-60. PubMed ID: 11059770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms.
    Boyle JJ; Weissberg PL; Bennett MR
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1553-8. PubMed ID: 12869351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
    Qin HY; Chaturvedi P; Singh B
    Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S; Koike N; Adachi S
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
    Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How melanoma cells evade trail-induced apoptosis.
    Hersey P; Zhang XD
    Nat Rev Cancer; 2001 Nov; 1(2):142-50. PubMed ID: 11905805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis: a case where too much or too little can lead to autoimmunity.
    Grodzicky T; Elkon KB
    Mt Sinai J Med; 2002 Sep; 69(4):208-19. PubMed ID: 12357262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
    Raine CS; Bonetti B; Cannella B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
    Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
    Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apo2L/TRAIL and its death and decoy receptors.
    LeBlanc HN; Ashkenazi A
    Cell Death Differ; 2003 Jan; 10(1):66-75. PubMed ID: 12655296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.